PCI Biotech and DCprime announced an extensive research collaboration
Goal is to develop novel cancer vaccines
Further development will depend on research outcome
Newly appointed CBO and increased focus on collaborator portfolio
01 Sep 2020
New research collaboration initiated
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
New research collaboration initiated
PCI Biotech Holding ASA (0JGL:LON) | 0 0 0.0%
- Published:
01 Sep 2020 -
Author:
Lars Mørland Knudsen -
Pages:
5
PCI Biotech and DCprime announced an extensive research collaboration
Goal is to develop novel cancer vaccines
Further development will depend on research outcome
Newly appointed CBO and increased focus on collaborator portfolio